| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/20/2008 | US20080070828 Ace-Inhibitory Whey Hydrolysates |
| 03/20/2008 | US20080070791 Libraries Of Chimeric Cellulose Binding Proteins And Methods Of Use Thereof |
| 03/20/2008 | US20080070306 Genetically modified plant comprising transcription factor sequences for enhancing efficacy of exogenous gene expression |
| 03/20/2008 | US20080070300 Human chemotactic cytokine |
| 03/20/2008 | US20080070298 Promoter of Synoviolin Gene |
| 03/20/2008 | US20080070280 Product quality enhancement in mammalian cell culture processes for protein production |
| 03/20/2008 | US20080070279 Group of Synthetic Antimicrobal Peptides |
| 03/20/2008 | US20080070278 Immunoglobulin fusion comprising clostridial light chain for use in controlling interaction of particular cell types with their external environment; drug targeting and delivery |
| 03/20/2008 | US20080070275 Factor VIII: Remodeling and glycoconjugation of factor VIII |
| 03/20/2008 | US20080070265 Using immunoglobulins specific to apolipoproteins as diagnostic tool in detection of cardiovascular disorders |
| 03/20/2008 | US20080070264 Using glial cell line derived neurotrophic factor receptor as tool in identifying modulator for prevention and treatment of cell proliferative disorders |
| 03/20/2008 | US20080070258 Polyamide nucleic acid derivatives and agents, and processes for preparing them |
| 03/20/2008 | US20080070252 CHR and POMC effects on animal growth |
| 03/20/2008 | US20080070232 Expression Vectors Containing a Truncated Epstein Barr Nuclear Antigen 1 Lacking the Gly-Gly-Ala Domain for Enhanced Transient Gene Expression |
| 03/20/2008 | US20080069839 Isolation and characterization of the precursor virus of human sars virus: sars-associated corona virus-like virus |
| 03/20/2008 | US20080069831 Vaccines; fusion protein; induce immunology response |
| 03/20/2008 | US20080069830 Isolation Dna; nucleotide sequences; genetic engineering |
| 03/20/2008 | US20080069829 Ability to bind to antibodies; diagnosis of allergies |
| 03/20/2008 | US20080069828 Detection of glandular disorders; bone disease ; calibrate different peptide fragments from whole parathyroid hormone; binding to antibody |
| 03/20/2008 | US20080069826 Novel Genes Associated with the Maintenance of Differentiation of Smooth Muscle Cells |
| 03/20/2008 | US20080069824 Size-variable strain-specific protective antigen for Potomac horse fever |
| 03/20/2008 | US20080069821 Avian pandemic; immunogens; antibodies; immunology |
| 03/20/2008 | US20080069815 Autoimmune diseases; rheumatic arthritis |
| 03/20/2008 | US20080069803 Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions vectors |
| 03/20/2008 | US20080069800 System for High Production of Natural and Personalized Interferons |
| 03/20/2008 | US20080069791 Administering composition of a polynucleotide, a polypeptide encoded by the nucleic acid and a compound which binds to an antibody which recognizes the polypeptide or binds to an IL- 15 receptor alpha chain; using a transgenic animal comprising an IL-15 polynucleotide |
| 03/20/2008 | US20080069774 Targeting ligand specifically binding to an extracellular component of a cellular system, masking the extracellular component from interacting with a component of the cellular system; thrombotic occlusion and loss of vessel patency at the site of the vascular intervention |
| 03/20/2008 | US20080069773 Novel Sodium Channel |
| 03/20/2008 | US20080069771 Oxygenated polymerized hemoglobin solutions and their uses for tissue visualization |
| 03/20/2008 | US20080069770 Monoclonal antibodies; used to modulate the immune system; no modulation of the totality of the T-cell population but only of the sub-assembly of T-cells expressing the beta sub-family specific to the T-cell receptors; used for organ transplant rejection |
| 03/20/2008 | US20080068245 A-d converter and a-d convert method |
| 03/20/2008 | DE102006041455A1 Verfahren zur Verbesserung der spezifischen Effektorfunktion von Einzelketten-Antigen-erkennenden genetischen Konstrukten (scARC) durch deren Murinisierung A method for improving the effector function of specific single-chain antigen-recognizing genetic constructs (scARC) through their murinization |
| 03/20/2008 | CA2663571A1 Methods for treating cancer |
| 03/20/2008 | CA2663498A1 Compositions and methods to prevent cancer with cupredoxins |
| 03/20/2008 | CA2663442A1 Cell culture improvements |
| 03/20/2008 | CA2663300A1 Polymer conjugates of box-a of hmgb1 and box-a variants of hmgb1 |
| 03/20/2008 | CA2663196A1 Making influenza virus vaccines without using eggs |
| 03/20/2008 | CA2663146A1 Expression of tgf-beta in plastids |
| 03/20/2008 | CA2663045A1 Nucleic acids for expressing a polynucleotide of interest in mammalian cancer cells |
| 03/20/2008 | CA2662622A1 Methods for administering long-lasting hypoglycemic agents |
| 03/20/2008 | CA2662549A1 Il-1 family variants |
| 03/20/2008 | CA2661224A1 Borrelia antigens |
| 03/19/2008 | EP1901069A1 Fret protease assays for clostridial toxins |
| 03/19/2008 | EP1900818A2 Neisserial antigens |
| 03/19/2008 | EP1900817A1 A bentazon and sulfonylurea herbicide-resistant gene cyp81a6 of rice |
| 03/19/2008 | EP1900816A2 GL50 molecules and uses therefor |
| 03/19/2008 | EP1900813A1 Novel physiological substance nesfatin, substance relevant thereto, and use of the substances |
| 03/19/2008 | EP1900749A1 Nucleic acids for expressing a polynucleotide of interest in mammalian cancer cells |
| 03/19/2008 | EP1900742A1 Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof |
| 03/19/2008 | EP1900377A1 Inhibitors of GPR87 for cancer therapy |
| 03/19/2008 | EP1900360A1 Homer a new target of treating psychiatric disorders |
| 03/19/2008 | EP1899477A2 An integrated approach for generating multidomain protein therapeutics |
| 03/19/2008 | EP1899470A2 System for rapid production of high-titer and replication-competent adenovirus-free recombinant adenovirus vectors |
| 03/19/2008 | EP1899460A2 Production of recombinant selenoprotein mutants with enhanced catalytic activity |
| 03/19/2008 | EP1899454A1 Serum-free culture medium for the production of recombinant gonadotropins |
| 03/19/2008 | EP1899375A1 New purification method of lactoferrin |
| 03/19/2008 | EP1899374A1 Synthetic ligands of peptide-mhc complexes, or cd1-antigen complexes |
| 03/19/2008 | EP1899373A2 Cspcna isoform modifications and uses thereof |
| 03/19/2008 | EP1899372A1 Composition and method for producing stable amyloid beta oligomers of high molecular weight |
| 03/19/2008 | EP1899371A2 Method for preparing a covalently cross linked oligomer of amyloid beta peptides |
| 03/19/2008 | EP1899370A1 A crystal structure and uses thereof |
| 03/19/2008 | EP1899369A2 Lefty, lefty derivatives and uses therof |
| 03/19/2008 | EP1899368A2 Interferon-igg fusion |
| 03/19/2008 | EP1899367A1 Mutant allergen(s) |
| 03/19/2008 | EP1899366A2 Genes of an otitis media isolate of nontypeable haemophilus influenzae |
| 03/19/2008 | EP1899363A1 Method for identifying modulators of rufy2 useful for treating alzheimer's disease |
| 03/19/2008 | EP1753780B1 Selective vpac2 receptor peptide agonists |
| 03/19/2008 | EP1708558A4 Proteins which confer biotic and abiotic stress resistance in plants |
| 03/19/2008 | EP1700916B1 Novel centromeric protein shugoshin |
| 03/19/2008 | EP1610803A4 Methods and kits for maintaining pregnancy, treating follicular cysts, and synchronizing ovulation using luteinizing hormone |
| 03/19/2008 | EP1513545B1 Methods and means to promote gut absorption |
| 03/19/2008 | EP1472339B1 A process for identifying a novel target for use for the development of therapeutic modalities and drugs effective against tuberculosis |
| 03/19/2008 | EP1428880B1 Kidney-specific urate transporter and gene thereof |
| 03/19/2008 | EP1326980B1 Methods of treatment using wisp polypeptides |
| 03/19/2008 | EP1306431B1 Tumor antigen |
| 03/19/2008 | EP1282437B1 Treatment of cartilage disorders |
| 03/19/2008 | EP1043328B1 Novel physiologically active substance sulphostin, process for producing the same, and use thereof |
| 03/19/2008 | EP1006195B1 INFECTIOUS VECTORS AND CLONES OF PLANTS DERIVED FROM THE TURNIP MOSAIC VIRUS (TuMV) |
| 03/19/2008 | EP0980240B1 Sustained-release compositions and method for preparing same |
| 03/19/2008 | EP0979279B1 Hemoglobin mutants with reduced nitric oxide scavenging |
| 03/19/2008 | EP0946716B1 Waxy wheat starch types having waxy proteins in granule |
| 03/19/2008 | EP0929564B1 High level expression of proteins |
| 03/19/2008 | EP0594669B9 Growth factor-responsive neural progenitor cells which can be proliferated in vitro. |
| 03/19/2008 | CN101146907A Gene inactivated mutants with altered protein production |
| 03/19/2008 | CN101146825A A molecule and chimeric molecules thereof |
| 03/19/2008 | CN101146824A Means and methods for breaking noncovalent binding interactions between molecules |
| 03/19/2008 | CN101146823A Molecules and chimeric molecules thereof |
| 03/19/2008 | CN101146822A EphB receptor-binding peptides |
| 03/19/2008 | CN101146821A Human cancer suppressor gene, protein encoded therein, expression vector containing the same, and cell transformed by the vector |
| 03/19/2008 | CN101146820A Production of polypeptides by improved secretion |
| 03/19/2008 | CN101146818A Methods and compositions for producing secreted trimeric receptor analogs and biologically active fusion proteins |
| 03/19/2008 | CN101146510A Long lasting waterproof sunscreen comprising metal oxide and peptide conditioner |
| 03/19/2008 | CN101144093A Recombination expression carrier and method for soluble expressing human I-type metallothionin |
| 03/19/2008 | CN101144086A Bioconversion of a fermentable carbon source to 1,3-propanediol by a single microorganism |
| 03/19/2008 | CN101144085A Anthracene nucleus antibiotic producing strain dnrX gene fragment, gene breaking engineering bacterium prepared from the same and application thereof |
| 03/19/2008 | CN101144084A Descurainiasophia cold-resisting gene DsCOR gene, preparation method and application thereof |
| 03/19/2008 | CN101144083A Descurainiasophia DsCBF gene, preparation method and application thereof |
| 03/19/2008 | CN101144082A Recombination human ciliary neurotrophy factor, mutant and application thereof |
| 03/19/2008 | CN101144081A Nucleic acid molecule TRAIL and application in preparation of anti-tumour pharmaceutical |
| 03/19/2008 | CN101144077A Method for preparing allophycocyanin fluorescence protein |